Brief: PMV Pharmaceuticals Q3 EPS USD -0.4
12/11/2025 13:00
Nov 12 (Reuters) - PMV Pharmaceuticals Q3 operating expenses USD 22.522 million. Q3 operating income USD -22.522 million Q3 net income USD -21.059 million
Recent news on Pmv Pharmaceuticals
See all newsAustralia's Premier Investments jumps as Citi backs in-line earnings
U.S. STOCKS ON THE MOVE- Medtronic, Comstock, Apple
U.S. STOCKS ON THE MOVE-GoPro, TXNM Energy, Emergent BioSolutions
U.S. STOCKS ON THE MOVE-Fervo Energy, Myriad Genetics, Emergent BioSolutions
U.S. STOCKS ON THE MOVE-Robinhood Markets, Park Hotels & Resorts, Capricor Therapeutics